-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acro Biomedical Co., Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2024.
- Acro Biomedical Co., Ltd. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$15.6K, a 53.4% decline year-over-year.
- Acro Biomedical Co., Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$46.8K, a 97.1% increase year-over-year.
- Acro Biomedical Co., Ltd. annual Net Income (Loss) Attributable to Parent for 2024 was -$42.3K, a 99.5% increase from 2023.
- Acro Biomedical Co., Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.81M, a 44.5% increase from 2022.
- Acro Biomedical Co., Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.9M, a 106% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)